ALFREDO SARDINAS: Open Payments
NPI 1174577985 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 13 payments from 7 companies in 2025. Trend: 2023 $296 · 2024 $34 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 5 | $133 |
| Octapharma USA, Inc. | 1 | $86 |
| ANI Pharmaceuticals, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $44 |
| Ossur Americas, Inc. | 1 | $42 |
| UCB, Inc. | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
Products named: ACTHAR, OCTAGAM IMMUNE GLOBULIN (HUMAN), PURIFIED CORTROPHIN GEL, KRYSTEXXA, Unloader One X, Bimzelx, STRENSIQ.
Industry payments across TX — which companies pay providers there.
